Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation.

@article{Chiladakis2001IntravenousMS,
  title={Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation.},
  author={John Chiladakis and Christos Stathopoulos and Periklis A. Davlouros and Antonis S Manolis},
  journal={International journal of cardiology},
  year={2001},
  volume={79 2-3},
  pages={
          287-91
        }
}
BACKGROUND Drugs currently available for the acute treatment of paroxysmal atrial fibrillation have significant limitations. We assessed the safety and effectiveness of intravenous magnesium sulfate versus diltiazem therapy in patients with prolonged episodes of paroxysmal atrial fibrillation. METHODS In a prospective randomized trial, 46 symptomatic patients presenting with paroxysmal atrial fibrillation were given intravenous magnesium sulfate (n=23) or diltiazem (n=23) therapy. Primary… CONTINUE READING
BETA

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 14 REFERENCES

Crit Care Med 1995;23:1816–24

  • A Arboix, L Garsia-Eroles, JB Massons, M Oliveres, R Pugades
  • Int J Cardiol Kjekshus J. The effect of magnesium…
  • 2000

Esmolol versus ventricular rate control in atrial fibrillation

  • JV Hays, JK Gilman, +4 authors G Das
  • Am J Cardiol
  • 1999

Hemodynamic effects

  • MC David, JP Vance, EE Andrew, K. Neal
  • J Am Coll Cardiol
  • 1997

Parenteral magnesium sulfate versus amiodarone in thefibrillation

  • MC David, JP Vance, +6 authors M Salagaras
  • J Am Coll Cardiol
  • 1997

The effect of magnesium versus verapamil on supraven2000 ; 73 : 33 – 42 . tricular arrhythmias

  • C Tauga, L Gullestad, +4 authors J IntJCardiolKjekshus
  • Clin Cardiol
  • 1993

Similar Papers

Loading similar papers…